Free Trial
→ Elon just did WHAT!? (From Brownstone Research) (Ad)
NASDAQ:GCTK

GlucoTrack 11/14/2023 Earnings Report

GlucoTrack logo
$0.18 +0.02 (+9.31%)
Closing price 05/5/2025 04:00 PM Eastern
Extended Trading
$0.17 -0.02 (-9.98%)
As of 06:53 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Earnings History

GlucoTrack EPS Results

Actual EPS
-$10.00
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

GlucoTrack Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

GlucoTrack Announcement Details

Quarter
Date
11/14/2023
Time
N/A
Conference Call Date
N/A
Conference Call Time
N/A

Upcoming Earnings

GlucoTrack's Q1 2025 earnings is scheduled for Wednesday, May 21, 2025

Conference Call Resources

GlucoTrack Earnings Headlines

GlucoTrack to participate in FORGETDIABETES initiative
April 17, 2025 | markets.businessinsider.com
Glucotrack to Participate in FORGETDIABETES, a Prominent European Research Initiative to Develop a Bionic Pancreas
April 16, 2025 | globenewswire.com
Elon just did WHAT!?
As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they gotten away with it, the Fed and U.S. banks could have seized control of our financial lives forever. But Trump stopped them cold on January 23rd, 2025, when he outlawed CBDCs… Paving the way for Elon Musk's secret master plan.
May 6, 2025 | Brownstone Research (Ad)
GlucoTrack, OneTwo Analytics collaborate to study analysis on CBG Monitor
April 5, 2025 | markets.businessinsider.com
Glucotrack and OneTwo Analytics to Collaborate for Clinical Study Analysis on Its Continuous Blood Glucose Monitor
April 3, 2025 | globenewswire.com
Glucotrack Reports Full Year 2024 Financial Results and Recent Corporate Highlights
March 31, 2025 | globenewswire.com
See More GlucoTrack Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like GlucoTrack? Sign up for Earnings360's daily newsletter to receive timely earnings updates on GlucoTrack and other key companies, straight to your email.

About GlucoTrack

GlucoTrack (NASDAQ:GCTK), a medical device company, focused on the design, development, and commercialization of novel technologies for people with diabetes in the United States. It develops GlucoTrack, a noninvasive glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Rutherford, New Jersey.

View GlucoTrack Profile

More Earnings Resources from MarketBeat

Earnings Tools
Earnings By Country
Latest Articles